Thus 4E5 mAb can be used to specifically recognize CgA in the small cell lung carcinomas (SCLC), adrenal gland tissues, and Islet cell carcinoma (Fig. 5). This evidence concerns the gene CGA and pancreatic endocrine carcinoma.